Market Estimates
Valuation Metrics
Financials
Trading Trends
BLTE News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Belite Bio Inc (BLTE) stock price today?
The current price of BLTE is 162.22 USD — it has decreased -1.09 % in the last trading day.
What is Belite Bio Inc (BLTE)'s business?
Belite Bio, Inc is a clinical-stage biopharmaceutical drug development company. The Company is focused on advancing novel therapeutics targeting retinal degenerative eye disease, such as Geographic Atrophy (GA), age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1), both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout. Its lead product candidate, Tinlarebant, is an oral daily treatment for STGD1 and GA patients. In STGD1, it is developing Tinlarebant as a once-a-day tablet treatment to target Retinol binding protein 4 (RBP4) by disrupting vitamin A (retinol) binding to RBP4, which leads to reduced delivery of retinol to the eye and reduced accumulation of toxic vitamin A by-products. Its product candidate also includes LBS-009, an anti-RBP4 oral therapy targeting liver disease, including NAFLD, NASH, and T2D.
What is the price predicton of BLTE Stock?
Wall Street analysts forecast BLTE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BLTE is 167.50 USD with a low forecast of 85.00 USD and a high forecast of 200.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Belite Bio Inc (BLTE)'s revenue for the last quarter?
Belite Bio Inc revenue for the last quarter amounts to -9.74M USD, decreased -0.00 % YoY.
What is Belite Bio Inc (BLTE)'s earnings per share (EPS) for the last quarter?
Belite Bio Inc. EPS for the last quarter amounts to USD, decreased % YoY.
What changes have occurred in the market's expectations for Belite Bio Inc (BLTE)'s fundamentals?
How many employees does Belite Bio Inc (BLTE). have?
Belite Bio Inc (BLTE) has 25 emplpoyees as of January 09 2026.
What is Belite Bio Inc (BLTE) market cap?
Today BLTE has the market capitalization of 6.15B USD.



![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260106220114_357efc7d1f3fd665b66477cc17a1f3e5.jpg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F436f3b64cc301d4e79234fbf17ab3a0aed11263875caa23a67755d055a5cf343.jpg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2Ffa81ebe13db903d3d9cf6495fdfcab4f2fd4bbd80d28ee2c5249ab97d38ed429.jpg&w=384&q=75)